In a recently announced settlement agreement with the U.S. Department of Justice (“DOJ”), Illumina, Inc. (“Illumina”) agreed to pay $9.8 million to resolve claims arising from alleged cybersecurity vulnerabilities in genomic sequencing systems that the company sold to federal agencies.  The case is the latest in a series of False Claims Act (“FCA”) settlements under the current administration that evidence DOJ’s continued focus on cybersecurity obligations for government contractors, particularly those that maintain sensitive data and personal information on behalf of federal customers.